SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001157523-19-000099
Filing Date
2019-01-22
Accepted
2019-01-22 07:00:30
Documents
2
Period of Report
2019-01-22

Document Format Files

Seq Description Document Type Size
1 AURINIA PHARMACEUTICALS INC. 6-K a51928791.htm 6-K 12818
2 EXHIBIT 99.1 a51928791ex99_1.htm EX-99.1 28333
  Complete submission text file 0001157523-19-000099.txt   42148
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 19534252
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1